In vitro and in vivo evaluation of 111In-labeled E. coli heat-stable enterotoxin analogs for specific targeting of human breast cancers

Breast Cancer Research and Treatment

Volumn 98, Issue 1, 2006, Pages 7-15

  Giblin, Michael F ^a,c   Gali, Hariprasad ^a   Sieckman, Gary L ^b   Owen, Nellie K ^a   Hoffman, Timothy J ^a,b,c   Volkert, Wynn A ^a,b   Forte, Leonard R ^a,b,c  

^a UNIVERSITY OF MISSOURI   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c University of Missouri   (United States)

Author keywords

Breast cancer; E. coli heat stable enterotoxin; Guanylate cyclase c; Indium 111; Uroguanylin

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID PHENYLALANINE 19 HEAT STABLE ENTEROTOXIN[1-19]; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID PHENYLALANINE 19 HEAT STABLE ENTEROTOXIN[1-19] IN 111; CELL SURFACE RECEPTOR; ESCHERICHIA COLI ENTEROTOXIN; ESTROGEN RECEPTOR; GUANYLATE CYCLASE; GUANYLIN RECEPTOR GUANYLATE CYCLASE C; IODINE 125; PEPTIDE DERIVATIVE; PHENYLALANINE 19 HEAT STABLE ENTEROTOXIN[1-19]; RADIOPHARMACEUTICAL AGENT; RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING COMPETITION; BREAST CANCER; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; CROSS LINKING; DRUG CLEARANCE; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG UPTAKE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; ISOTOPE LABELING; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR XENOGRAFT; URINARY EXCRETION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; COLONIC NEOPLASMS; CROSS-LINKING REAGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; ENTEROTOXINS; ESCHERICHIA COLI; FEMALE; HUMANS; INDIUM RADIOISOTOPES; INHIBITORY CONCENTRATION 50; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; PROTEIN BINDING;

EID: 33745874115     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9040-8     Document Type: Article

References (30)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ: Cancer Statistics, 2004. CA Cancer J Clin 54: 8-29, 2004
2. Mankoff DA, Dunnwald LK, Kinahan P: Are we ready for dedicated breast imaging approaches?. J Nucl Med 44: 594-595, 2003
3. Wahl RL, Siegel BA, Coleman RE, Gatsonis CG: Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group. J Clin Oncol 22: 277-285, 2004
4. Sampalis FS, Denis R, Picard D, Fleiszer D, Martin G, Nassif E, Sampalis JS: International prospective evaluation of scintimammography with (99m)technetium sestamibi. Am J Surg 185: 544-549, 2003
5. Koizumi M, Nomura E, Yamada Y, Takiguchi T, Tanaka K, Yoshimoto M, Makita M, Sakamoto G, Kasumi F, Ogata E: Sentinel node detection using 99mTc-rhenium sulphide colloid in breast cancer patients: evaluation of 1 day and 2 day protocols, and a dose-finding study. Nucl Med Commun 24: 663-670, 2003
6. Signore A, Annovazzi A, Chianelli M, Corsetti F, Van de Wiele C, Watherhouse RN, Scopinaro F: Peptide radiopharmaceuticals for diagnosis and therapy. Eur J Nucl Med 28: 1555-1565, 2001
7. Britz-Cunningham SH, Adelstein SJ: Molecular targeting with radionuclides: state of the science. J Nucl Med 44: 1945-1961, 2003
8. Reubi JC: Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocrine Rev 24: 389-427, 2003
9. Bajc M, Ingvar C, Palmer J: Dynamic indium-111-pentetreotide scintigraphy in breast cancer. J Nucl Med 37: 622-626, 1996
10. Alberini JL, Meunier B, Denzler B, Devillers A, Tass P, Dazord L, Le Simple T, Laissue J, de Jong R, Le Cloirec J, Reubi JC, Bourguet P: Somatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiography. Breast Cancer Res Treat 61: 21-32, 2000
11. Thakur ML, Marcus CS, Saeed S, Pallela V, Minami C, Diggles L, Pham HL, Ahdoot R, Kalinowski EA, Moody T: Imaging tumors in humans with Tc-99m-VIP. Ann NY Acad Sci 921: 37-44, 2000
12. Moody TW, Leyton J, Gozes I, Lang L, Eckelman WC: VIP and breast cancer. Ann NY Acad Sci 865: 290-296, 1998
13. Scopinaro F, Varvarigou AD, Ussof W, De Vincentis G, Sourlingas TG, Evangelatos GP, Datsteris J, Archimandritis SC: Technetium labeled bombesin-like peptide: preliminary report on breast cancer uptake in patients. Cancer Biother Radiopharm 17: 327-335, 2002
14. Van de Wiele C, Dumont F, Vanden Broecke R, Oosterlinck W, Cocquyt V, Serreyn R, Peers S, Thornback J, Slegers G, Dierckx RA: Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study. Eur J Nucl Med 27: 1694-1699, 2000
15. h) produced by a human strain of enterotoxigenic Escherichia coli. FEBS Lett 215: 165-170, 1987
16. Gariepy J, Judd AK, Schoolnik GK: Importance of disulfide bridges in the structure and activity of Escherichia coli enterotoxin ST1b. Proc Natl Acad Sci USA 84: 8907-8911, 1987
17. Forte L: Guanylin regulatory peptides: structures, biological activities mediated by cyclic GMP and pathobiology. Reg Peptides 81: 25-39, 1999
18. Schulz S, Green CK, Yuen PS, Garbers DL: Guanylyl cyclase is a heat-stable enterotoxin receptor. Cell 63: 941-948, 1990
19. Forte LR: Uroguanylin, guanylin peptides: pharmacology and experimental therapeutics. Pharmacol Therap 104: 137-162, 2004
20. 111In-DOTA group and distinct linker moieties. Bioconj Chem 15: 872-880, 2004
21. 111In-labeled ST-peptide analog for specific targeting of human colon cancers. Nucl Med Biol 28: 903-909, 2001
22. 111In-labeled ST-peptide enterotoxin (ST) analog for specific targeting of guanylin receptors on human colonic cancers. Anticancer Res 21: 2785-2792, 2001
23. 111In-DOTA- Phe19-STh analog for specific targeting of human colon cancers. Bioconj Chem 13: 224-231, 2002
24. Wolfe HR, Mendizabal M, Lleong E, Cuthbertson A, Desai V, Pullan S, Fujii DK, Morrison M, Pither R, Waldman SA: In vivo imaging of human colon cancer xenografts in immunodeficient mice using a guanylyl cyclase C-specific ligand. J Nucl Med 43: 392-399, 2002
25. Kubota H, Hidaka Y, Ozaki H, Ito H, Hirayama T, Takeda Y, Shimonishi Y: A long-acting heat-stable enterotoxin analog of enterotoxigenic Escherichia coli with a single D-amino acid. Biochem Biophys Res Comm 161: 229-235, 1989
26. Carrithers SL, Parkinson SJ, Goldstein S, Park P, Robertson DC, Waldman SA: Escherichia coli heat-stable toxin receptors in human colonic tumors. Gastroenterologia 107: 1653-1661, 1994
27. Mann EA, Cohen MB, Giannella RA: Comparison of receptors for Escherichia coli heat-stable enterotoxin: novel receptor present in IEC-6 cells. Am J Physiol 27: G172-G178, 1993
28. Albano F, Brasitus T, Mann EA, Guarino A, Giannella RA: Colonocyte basolateral membranes contain Escherichia coli heat-stable enterotoxin receptors. Biochem Biophys Res Comm 284: 331-334, 2001
29. Carrithers SL, Ott CE, Hill MJ, Johnson BR, Cai W, Chang JJ, Shah RG, Sun C, Mann EA, Fonteles MC, Forte LR, Jackson BA, Giannella RA, Greenberg RN: Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor. Kidney Int 65: 40-53, 2004
30. Carrithers SL, Barber MT, Biswas S, Parkinson SJ, Park PK, Goldstein SD, Waldman SA: Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues. Proc Natl Acad Sci USA 93: 14827-14832, 1996